Burke Steven Keith

Number of records: 34
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
01-Mar-24 5:46 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 29-Feb-24Sale 7,169$1.58$11,327.00(1%)
703.01K to 695.84K
29-Feb-24 6:01 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 27-Feb-24Sale (Planned) 8,367$1.52$12,717.80(1%)
711.38K to 703.01K
02-Feb-24 4:10 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 01-Feb-24Sale 24,311$1.68$40,842.50(3%)
735.69K to 711.38K
02-Feb-24 4:10 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 31-Jan-24Grant 202,200----38%
533.49K to 735.69K
09-May-24 5:27 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 25-Aug-23Sale 27,000$1.15$31,050.00(4%)
695.84K to 668.84K
18-May-23 6:20 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 16-May-23Sale 63,567$1.07$67,889.60(11%)
594.05K to 530.49K
03-Mar-23 8:01 AM
View: 
Akebia Therapeutics, Inc. (AKBA) 01-Mar-23Sale 14,123$0.88$12,392.90(2%)
608.18K to 594.05K
01-Mar-23 4:06 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 27-Feb-23Sale 7,539$0.81$6,130.71(1%)
615.72K to 608.18K
02-Feb-23 4:14 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 31-Jan-23Grant 196,200----47%
419.52K to 615.72K
01-Sep-22 4:15 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 31-Aug-22Sale 1,147$0.36$415.79(< 1%)
419.16K to 418.02K
16-May-22 4:08 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 12-May-22Grant 200,000----92%
217.66K to 417.66K
02-Mar-22 9:12 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 01-Mar-22Sale 7,656$2.17$16,618.90(3%)
225.32K to 217.66K
02-Mar-22 9:12 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 28-Feb-22Grant 60,000----35%
171.22K to 231.22K
02-Mar-22 9:12 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 28-Feb-22Sale 7,400$2.15$15,945.50(3%)
231.22K to 223.82K
01-Apr-21 8:31 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 01-Apr-21Market Sale 1,081$3.40$3,675.40(< 1%)
171.84K to 170.76K
< 1%
18-Mar-21 7:16 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 16-Mar-21Grant 10,400----6%
161.44K to 171.84K
02-Mar-21 4:06 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 01-Mar-21Market Sale 7,558$3.40$25,667.70(4%)
169.0K to 161.44K
02-Mar-21 4:06 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 26-Feb-21Grant 70,000----71%
99.0K to 169.0K
02-Mar-20 7:25 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 28-Feb-20Grant 62,000----168%
37.0K to 99.0K
22-Nov-19 6:19 AM
View: 
Akebia Therapeutics, Inc. (AKBA) 20-Nov-19Market Purchase 27,000$3.58$96,660.00270%
10.0K to 37.0K
(16%)
04-Sep-19 4:03 PM
View: 
Akebia Therapeutics, Inc. (AKBA) 30-Aug-19Grant 10,000----100%
0 to 10.0K
18-Mar-19 8:15 AM
View: 
Protara Therapeutics, Inc. (TARA) 15-Mar-19Gift 14,666----9%
154.58K to 169.25K
18-Mar-19 8:15 AM
View: 
Protara Therapeutics, Inc. (TARA) 15-Mar-19Gift 22,000----(13%)
169.25K to 147.25K
03-Jan-19 8:19 AM
View: 
Protara Therapeutics, Inc. (TARA) 31-Dec-18Grant 2,448$1.93$4,724.642%
133.13K to 135.58K
03-Jul-18 8:19 AM
View: 
Protara Therapeutics, Inc. (TARA) 29-Jun-18Grant 10,000$1.62$16,150.00(7%)
143.13K to 133.13K
(15%)
03-Jan-18 8:15 AM
View: 
Protara Therapeutics, Inc. (TARA) 29-Dec-17Grant 3,934$1.30$5,098.46(3%)
127.07K to 123.14K
18-Dec-17 5:11 PM
View: 
Protara Therapeutics, Inc. (TARA) 15-Dec-17Gift 6,666----6%
118.87K to 125.53K
18-Dec-17 5:11 PM
View: 
Protara Therapeutics, Inc. (TARA) 15-Dec-17Gift 10,000----(7%)
137.53K to 127.53K
18-Dec-17 5:11 PM
View: 
Protara Therapeutics, Inc. (TARA) 15-Dec-17Market Purchase 12,000$1.88$22,560.0010%
125.53K to 137.53K
(88%)
05-Jul-17 4:10 PM
View: 
Protara Therapeutics, Inc. (TARA) 30-Jun-17Grant 10,000$1.30$12,960.00(8%)
120.53K to 110.53K
82%
13-Mar-17 5:00 PM
View: 
Protara Therapeutics, Inc. (TARA) 10-Mar-17Option Exercise 70,221$1.46$102,819.00277%
25.31K to 95.53K
06-Dec-16 4:30 PM
View: 
Protara Therapeutics, Inc. (TARA) 02-Dec-16Gift 5,000----14%
35.31K to 40.31K
06-Dec-16 4:30 PM
View: 
Protara Therapeutics, Inc. (TARA) 02-Dec-16Gift 7,500----(19%)
40.31K to 32.81K
08-Jul-15 8:00 AM
View: 
Protara Therapeutics, Inc. (TARA) 30-Jun-15Grant 2,403$8.84$21,242.508%
30.41K to 32.81K